Biogena Group Invest AG (WBO:BIO) Capex-to-Operating-Income : 0.00 (As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Biogena Group Invest AG's Capital Expenditure for the six months ended in Jan. 2024 was €0.00 Mil. Its Operating Income for the six months ended in Jan. 2024 was €0.00 Mil.

Hence, Biogena Group Invest AG's Capex-to-Operating-Income for the six months ended in Jan. 2024 was 0.00.

Biogena Group Invest AG Capex-to-Operating-Income Historical Data

The historical data trend for Biogena Group Invest AG's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Capex-to-Operating-Income Chart

Biogena Group Invest AG Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Capex-to-Operating-Income

Biogena Group Invest AG Semi-Annual Data
	Jan21	Jan22	Jan23	Jan24
Capex-to-Operating-Income	-	-	-	-

Competitive Comparison of Biogena Group Invest AG's Capex-to-Operating-Income

For the Packaged Foods subindustry, Biogena Group Invest AG's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biogena Group Invest AG's Capex-to-Operating-Income Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Capex-to-Operating-Income falls into.

Biogena Group Invest AG Capex-to-Operating-Income Calculation

Biogena Group Invest AG's Capex-to-Operating-Income for the fiscal year that ended in Jan. 2024 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (0)	/	0.003
	=	0.00

Biogena Group Invest AG's Capex-to-Operating-Income for the quarter that ended in Jan. 2024 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (0)	/	0.003
	=	0.00

Biogena Group Invest AG (WBO:BIO) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Biogena Group Invest AG Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogena Group Invest AG (WBO:BIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Strubergasse 24, Salzburg, AUT, 5020

Website

https://www.biogenagroup.com

Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.